Akeso lung cancer drug shines in trials, boosting hopes in US$20b market
Akeso, whose drug ivonescimab was hailed as biotech's "DeepSeek moment" amid US competition last year, announced better-than-expected clinical results showing it can treat a type of lung cancer commonly found …


